{
    "info": {
        "nct_id": "NCT05020860",
        "official_title": "A Phase II Trial to Correlate Early Clinical Response to Pathologic Outcome With Neoadjuvant Systemic Therapy in Patients With Early Stage Breast Cancer",
        "inclusion_criteria": "* At least 18 years of age, and legally able to provide informed consent. Both men and women are eligible.\n* Histologically confirmed, invasive breast cancer. Tumor may be triple negative (as defined by ASCO-CAP guidelines), HER2-positive (as defined by ASCO-CAP guidelines), or high-risk estrogen receptor positive (as defined by ASCO-CAP guidelines).\n\nTo be considered \"high risk,\" at least 2 of the following criteria must be met: 1) histologic grade 3; 2) patient age 50 or less; 3) ER Allred score < 6; 4) Ki-67 ≥ 30%.\n\n* Tumors must be at least 2 cm by clinical exam or ultrasound\n* Bilateral breast cancers are allowed if the following criteria are met: 1) A lesion on one side (meeting the criteria above) is designated as the index lesion on which study assessments will be performed, and 2) the same treatment regimen is appropriate for both cancers as determined by the treating physician.\n* ECOG performance status of 0 or 1\n* Left ventricular ejection fraction (LVEF) ≥ the institutional lower limit of normal, as assessed by echocardiogram or Multigated Acquisition (MUGA )scan.\n* Adequate organ function, as determined by the following parameters:\n\n  * Absolute Neutrophil Count (ANC) ≥ 1200/mm3\n  * Platelets ≥ 100,000/mm3\n  * Hemoglobin ≥ 9 g/dL\n  * Total bilirubin ≤ institutional upper limit of normal (ULN), unless patient has Gilbert's disease or similar syndrome\n  * Alkaline phosphatase (ALP) ≤ 2.5 x institutional ULN\n  * Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 1.5 x institutional ULN\n  * Serum creatinine ≤ institutional ULN\n* The participant, if of childbearing potential, is willing to use effective, non-hormonal contraception while on treatment.\n* Participation in a concurrent clinical trial is permitted, with Principal Investigator approval.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Definitive clinical or radiologic evidence of Stage IV disease\n* Inflammatory breast cancer\n* Participants who are pregnant or lactating\n* History of an excisional biopsy or lumpectomy performed prior to study entry\n* Prior treatment with anthracyclines for any malignancy.\n* Prior treatment for currently diagnosed breast cancer (i.e., endocrine therapy, chemotherapy, targeted therapy, or radiation.\n* History of cardiac disease that would preclude the use of drugs included in these treatment regimens. This includes, but is not limited to:\n\n  * Angina pectoris requiring the use of anti-anginal medication\n  * Ventricular arrhythmias except for benign premature ventricular contractions\n  * Supraventricular and nodal arrhythmias requiring a pacemaker or not controlled with medication\n  * Conduction abnormality requiring a pacemaker\n  * Valvular disease with documented compromise in cardiac function\n  * Symptomatic pericarditis\n  * Documented cardiomyopathy\n  * History of documented congestive heart failure (CHF)\n  * Myocardial infarction documented by elevated cardiac enzymes, or persistent regional wall abnormalities on assessment of left ventricular function.\n* Current HIV, hepatitis B, or hepatitis C infection\n* History of non-breast malignancies (with the exception of in situ cancers treated only by local excision, and basal cell or squamous cell carcinoma of the skin) within 5 years prior to enrollment.\n* Any other non-malignant systemic disease that would preclude treatment with any of the treatment regimens or prevent required follow-up.\n* Any psychiatric or addictive disorders, adverse social situations, or other medical conditions that, in the opinion of the investigator, would preclude the patient from meeting study requirements.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Tumors must be at least 2 cm by clinical exam or ultrasound",
            "criterions": [
                {
                    "exact_snippets": "Tumors must be at least 2 cm by clinical exam or ultrasound",
                    "criterion": "tumor size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* At least 18 years of age, and legally able to provide informed consent. Both men and women are eligible.",
            "criterions": [
                {
                    "exact_snippets": "At least 18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "legally able to provide informed consent",
                    "criterion": "legal ability to provide informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Both men and women are eligible",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelets ≥ 100,000/mm3",
            "criterions": [
                {
                    "exact_snippets": "Platelets ≥ 100,000/mm3",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "mm3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin ≤ institutional upper limit of normal (ULN), unless patient has Gilbert's disease or similar syndrome",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin ≤ institutional upper limit of normal (ULN)",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unless patient has Gilbert's disease or similar syndrome",
                    "criterion": "Gilbert's disease or similar syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participation in a concurrent clinical trial is permitted, with Principal Investigator approval.",
            "criterions": [
                {
                    "exact_snippets": "Participation in a concurrent clinical trial is permitted",
                    "criterion": "participation in a concurrent clinical trial",
                    "requirements": [
                        {
                            "requirement_type": "permission",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "with Principal Investigator approval",
                    "criterion": "Principal Investigator approval",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum creatinine ≤ institutional ULN",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine ≤ institutional ULN",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "institutional ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate organ function, as determined by the following parameters:",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute Neutrophil Count (ANC) ≥ 1200/mm3",
            "criterions": [
                {
                    "exact_snippets": "Absolute Neutrophil Count (ANC) ≥ 1200/mm3",
                    "criterion": "Absolute Neutrophil Count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1200,
                                "unit": "mm3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 1.5 x institutional ULN",
            "criterions": [
                {
                    "exact_snippets": "Aspartate aminotransferase (AST) ... ≤ 1.5 x institutional ULN",
                    "criterion": "aspartate aminotransferase (AST) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x institutional ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "alanine aminotransferase (ALT) ≤ 1.5 x institutional ULN",
                    "criterion": "alanine aminotransferase (ALT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x institutional ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically confirmed, invasive breast cancer. Tumor may be triple negative (as defined by ASCO-CAP guidelines), HER2-positive (as defined by ASCO-CAP guidelines), or high-risk estrogen receptor positive (as defined by ASCO-CAP guidelines).",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed, invasive breast cancer",
                    "criterion": "breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "invasiveness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Tumor may be triple negative (as defined by ASCO-CAP guidelines)",
                    "criterion": "tumor receptor status",
                    "requirements": [
                        {
                            "requirement_type": "triple negative",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "HER2-positive (as defined by ASCO-CAP guidelines)",
                    "criterion": "tumor receptor status",
                    "requirements": [
                        {
                            "requirement_type": "HER2 status",
                            "expected_value": "positive"
                        }
                    ]
                },
                {
                    "exact_snippets": "high-risk estrogen receptor positive (as defined by ASCO-CAP guidelines)",
                    "criterion": "tumor receptor status",
                    "requirements": [
                        {
                            "requirement_type": "estrogen receptor status",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "risk level",
                            "expected_value": "high"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Bilateral breast cancers are allowed if the following criteria are met: 1) A lesion on one side (meeting the criteria above) is designated as the index lesion on which study assessments will be performed, and 2) the same treatment regimen is appropriate for both cancers as determined by the treating physician.",
            "criterions": [
                {
                    "exact_snippets": "Bilateral breast cancers are allowed if the following criteria are met: 1) A lesion on one side (meeting the criteria above) is designated as the index lesion on which study assessments will be performed",
                    "criterion": "index lesion designation",
                    "requirements": [
                        {
                            "requirement_type": "designation",
                            "expected_value": "A lesion on one side is designated as the index lesion"
                        }
                    ]
                },
                {
                    "exact_snippets": "the same treatment regimen is appropriate for both cancers as determined by the treating physician",
                    "criterion": "treatment regimen appropriateness for both cancers",
                    "requirements": [
                        {
                            "requirement_type": "appropriateness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "determined by",
                            "expected_value": "treating physician"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Left ventricular ejection fraction (LVEF) ≥ the institutional lower limit of normal, as assessed by echocardiogram or Multigated Acquisition (MUGA )scan.",
            "criterions": [
                {
                    "exact_snippets": "Left ventricular ejection fraction (LVEF) ≥ the institutional lower limit of normal",
                    "criterion": "left ventricular ejection fraction (LVEF)",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0,
                                "unit": "institutional lower limit of normal"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "as assessed by echocardiogram or Multigated Acquisition (MUGA )scan",
                    "criterion": "assessment method for LVEF",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": [
                                "echocardiogram",
                                "Multigated Acquisition (MUGA) scan"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "To be considered \"high risk,\" at least 2 of the following criteria must be met: 1) histologic grade 3; 2) patient age 50 or less; 3) ER Allred score < 6; 4) Ki-67 ≥ 30%.",
            "criterions": [
                {
                    "exact_snippets": "histologic grade 3",
                    "criterion": "histologic grade",
                    "requirements": [
                        {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": "=",
                                "value": 3,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "patient age 50 or less",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": "<=",
                                "value": 50,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "ER Allred score < 6",
                    "criterion": "ER Allred score",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<",
                                "value": 6,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Ki-67 ≥ 30%",
                    "criterion": "Ki-67",
                    "requirements": [
                        {
                            "requirement_type": "percentage",
                            "expected_value": {
                                "operator": ">=",
                                "value": 30,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Alkaline phosphatase (ALP) ≤ 2.5 x institutional ULN",
            "criterions": [
                {
                    "exact_snippets": "Alkaline phosphatase (ALP) ≤ 2.5 x institutional ULN",
                    "criterion": "alkaline phosphatase (ALP) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x institutional ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status of 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin ≥ 9 g/dL",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin ≥ 9 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The participant, if of childbearing potential, is willing to use effective, non-hormonal contraception while on treatment.",
            "criterions": [
                {
                    "exact_snippets": "if of childbearing potential",
                    "criterion": "childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willing to use effective, non-hormonal contraception while on treatment",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "effective, non-hormonal"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "while on treatment"
                        },
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Symptomatic pericarditis",
            "criterions": [
                {
                    "exact_snippets": "Symptomatic pericarditis",
                    "criterion": "pericarditis",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of documented congestive heart failure (CHF)",
            "criterions": [
                {
                    "exact_snippets": "History of documented congestive heart failure (CHF)",
                    "criterion": "congestive heart failure (CHF)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Inflammatory breast cancer",
            "criterions": [
                {
                    "exact_snippets": "Inflammatory breast cancer",
                    "criterion": "inflammatory breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Supraventricular and nodal arrhythmias requiring a pacemaker or not controlled with medication",
            "criterions": [
                {
                    "exact_snippets": "Supraventricular and nodal arrhythmias requiring a pacemaker",
                    "criterion": "supraventricular and nodal arrhythmias",
                    "requirements": [
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "requiring a pacemaker"
                        }
                    ]
                },
                {
                    "exact_snippets": "Supraventricular and nodal arrhythmias ... not controlled with medication",
                    "criterion": "supraventricular and nodal arrhythmias",
                    "requirements": [
                        {
                            "requirement_type": "control with medication",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants who are pregnant or lactating",
            "criterions": [
                {
                    "exact_snippets": "pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lactating",
                    "criterion": "lactation status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of non-breast malignancies (with the exception of in situ cancers treated only by local excision, and basal cell or squamous cell carcinoma of the skin) within 5 years prior to enrollment.",
            "criterions": [
                {
                    "exact_snippets": "History of non-breast malignancies ... within 5 years prior to enrollment.",
                    "criterion": "non-breast malignancies",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since diagnosis or treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "with the exception of in situ cancers treated only by local excision",
                    "criterion": "in situ cancers treated only by local excision",
                    "requirements": [
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "basal cell or squamous cell carcinoma of the skin",
                    "criterion": "basal cell carcinoma of the skin",
                    "requirements": [
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "basal cell or squamous cell carcinoma of the skin",
                    "criterion": "squamous cell carcinoma of the skin",
                    "requirements": [
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Definitive clinical or radiologic evidence of Stage IV disease",
            "criterions": [
                {
                    "exact_snippets": "Definitive clinical or radiologic evidence of Stage IV disease",
                    "criterion": "Stage IV disease",
                    "requirements": [
                        {
                            "requirement_type": "evidence",
                            "expected_value": [
                                "clinical",
                                "radiologic"
                            ]
                        },
                        {
                            "requirement_type": "definitiveness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Conduction abnormality requiring a pacemaker",
            "criterions": [
                {
                    "exact_snippets": "Conduction abnormality requiring a pacemaker",
                    "criterion": "conduction abnormality",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "requiring a pacemaker"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Myocardial infarction documented by elevated cardiac enzymes, or persistent regional wall abnormalities on assessment of left ventricular function.",
            "criterions": [
                {
                    "exact_snippets": "Myocardial infarction documented by elevated cardiac enzymes",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "documentation",
                            "expected_value": "elevated cardiac enzymes"
                        }
                    ]
                },
                {
                    "exact_snippets": "persistent regional wall abnormalities on assessment of left ventricular function",
                    "criterion": "regional wall abnormalities of left ventricle",
                    "requirements": [
                        {
                            "requirement_type": "persistence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Angina pectoris requiring the use of anti-anginal medication",
            "criterions": [
                {
                    "exact_snippets": "Angina pectoris requiring the use of anti-anginal medication",
                    "criterion": "angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "medication requirement",
                            "expected_value": "use of anti-anginal medication"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Documented cardiomyopathy",
            "criterions": [
                {
                    "exact_snippets": "Documented cardiomyopathy",
                    "criterion": "cardiomyopathy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ventricular arrhythmias except for benign premature ventricular contractions",
            "criterions": [
                {
                    "exact_snippets": "Ventricular arrhythmias except for benign premature ventricular contractions",
                    "criterion": "ventricular arrhythmias",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": "not benign premature ventricular contractions"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of cardiac disease that would preclude the use of drugs included in these treatment regimens. This includes, but is not limited to:",
            "criterions": [
                {
                    "exact_snippets": "History of cardiac disease that would preclude the use of drugs included in these treatment regimens",
                    "criterion": "cardiac disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "impact on treatment",
                            "expected_value": "would preclude the use of drugs included in these treatment regimens"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current HIV, hepatitis B, or hepatitis C infection",
            "criterions": [
                {
                    "exact_snippets": "Current HIV ... infection",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current_status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Current ... hepatitis B ... infection",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current_status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Current ... hepatitis C ... infection",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current_status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any other non-malignant systemic disease that would preclude treatment with any of the treatment regimens or prevent required follow-up.",
            "criterions": [
                {
                    "exact_snippets": "Any other non-malignant systemic disease that would preclude treatment with any of the treatment regimens or prevent required follow-up.",
                    "criterion": "non-malignant systemic disease",
                    "requirements": [
                        {
                            "requirement_type": "impact on treatment",
                            "expected_value": "would preclude treatment with any of the treatment regimens"
                        },
                        {
                            "requirement_type": "impact on follow-up",
                            "expected_value": "would prevent required follow-up"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of an excisional biopsy or lumpectomy performed prior to study entry",
            "criterions": [
                {
                    "exact_snippets": "History of an excisional biopsy or lumpectomy performed prior to study entry",
                    "criterion": "excisional biopsy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "performed prior to study entry"
                        }
                    ]
                },
                {
                    "exact_snippets": "History of an excisional biopsy or lumpectomy performed prior to study entry",
                    "criterion": "lumpectomy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "performed prior to study entry"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment with anthracyclines for any malignancy.",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with anthracyclines for any malignancy.",
                    "criterion": "prior treatment with anthracyclines",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "indication",
                            "expected_value": "any malignancy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment for currently diagnosed breast cancer (i.e., endocrine therapy, chemotherapy, targeted therapy, or radiation.",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment for currently diagnosed breast cancer (i.e., endocrine therapy, chemotherapy, targeted therapy, or radiation",
                    "criterion": "prior treatment for currently diagnosed breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment type",
                            "expected_value": [
                                "endocrine therapy",
                                "chemotherapy",
                                "targeted therapy",
                                "radiation"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Valvular disease with documented compromise in cardiac function",
            "criterions": [
                {
                    "exact_snippets": "Valvular disease",
                    "criterion": "valvular disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "documented compromise in cardiac function",
                    "criterion": "cardiac function",
                    "requirements": [
                        {
                            "requirement_type": "compromise",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any psychiatric or addictive disorders, adverse social situations, or other medical conditions that, in the opinion of the investigator, would preclude the patient from meeting study requirements.",
            "criterions": [
                {
                    "exact_snippets": "Any psychiatric or addictive disorders",
                    "criterion": "psychiatric or addictive disorders",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "adverse social situations",
                    "criterion": "adverse social situations",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "other medical conditions that, in the opinion of the investigator, would preclude the patient from meeting study requirements",
                    "criterion": "other medical conditions (per investigator opinion)",
                    "requirements": [
                        {
                            "requirement_type": "impact on study participation",
                            "expected_value": "would preclude the patient from meeting study requirements"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}